Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You guys are correct... my mistake... how stupid and embarrassing...
70,000,000,000/305,291,099(US population) equals $229.29/person... If my math's correct, that seems like a reasonable amount to contribute to save the world as we know it...
Uh, Cap, I think your math is off by a factor of about 1000...
Yea...that would sure teach those guys with the golden parachutes a lesson...the only people who ever suffer financially are the ones without enough money
According to Yahoo, QLD will be at an all-time split- and dividend-adjusted closing low if it closes below 54.34...
I wonder why QID is so far (~40%) from it's all-time high...
Why would McCain cut it in half? He supports hESC research, though Palin doesn't. In any case, the Congress should have a veto-proof majority in favor of such research.
Thanks, steviee. Appreciate your consistent, reliable info.
That's what he's doing. You just dont seem to like the criteria he's apparently decided to use...
Which Monday?
Is there a better way?
We should be so fortunate...
Why?
I guess they haven't filled you in yet. No problem. Forget I asked.
Well, since I'm currently nearly fully invested in QLD, I hope that they continue to do what they have been doing recently. Since I've noticed that you are on the correct side of a trade more often than not, I'd like to know where you see them pushing this market over the medium term. Which way do you see us moving after the big dogs come back after their summer R&R??
Suits me, heheheh. BTW, who are "they"?
From Briefing.com:
"06:29 am : S&P futures vs fair value: +0.7. Nasdaq futures vs fair value: +26.8"
Sure...
Can't keep this market down... Is it going to melt up for a while?
"Nymex crude is down about $33, or 22 percent, from its high of $147.27"
Can somebody tell me where I can see a chart showing this action? What symbol at which source? Thanks in advance.
I've been using Fidelity since the early nineties, and agree 100 percent with Tinner
Can you give a rational explanation for why we would follow that pattern?
I guess not very......
How important is this?
http://biz.yahoo.com/bw/080602/20080602005476.html?.v=1
Geron Presentations at the ASCO 2008 Annual Meeting
Monday June 2, 7:30 am ET
New Data on Activity of GRN163L in T-cell Prolymphocytic Leukemia Cells
MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq:GERN - News) today announced two presentations of its anti-cancer drug, GRN163L, given at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago.
Geron is currently testing GRN163L in four clinical trials with 15 U.S. medical centers recruiting patients with solid tumors, chronic lymphoproliferative disease, multiple myeloma and non-small cell lung cancer. New combination trials in breast cancer and multiple myeloma at additional trial sites are scheduled to initiate in the coming months. Geron is also conducting a multi-center Phase II trial of GRNVAC1, a telomerase therapeutic vaccine, in high risk acute myelogenous leukemia (AML) patients. We expect Merck & Co., Inc., under license from Geron, to initiate a therapeutic vaccine trial targeting telomerase in patients with non-small cell lung and prostate cancers.
GRN163L Exhibits Rapid and Selective Cytotoxicity in T-PLL Cells
T-cell prolymphocytic leukemia (T-PLL) is an aggressive lymphoproliferative disease characterized by resistance to chemotherapy, high telomerase activity and very short telomeres (R th, et. al., Leukemia, 21:2456-2462, 2007). In a poster presentation authored by Geron scientists and collaborators from the University Hospital, Essen, Germany and the University Hospital, Bern, Switzerland, T-PLL cells from patients were selectively killed in dose-dependent fashion by seven-day incubations with GRN163L. Annexin staining confirmed a dose-dependent increase in apoptosis caused by exposure to GRN163L. Normal T-cells were unaffected by GRN163L, and a mismatch control oligonucleotide had no effect on the viability of the leukemic cells.
The results demonstrate selective cytotoxicity of GRN163L on T-PLL cells leading to rapid leukemic cell death and provide the rationale for clinical trials of GRN163L in patients with T-PLL.
Phase I Study of GRN163L in Refractory, Advanced Solid Tumors
Interim analysis of an ongoing Phase I study of GRN163L in refractory, advanced solid tumor patients was presented by Geron scientists and collaborating principal investigators from the University of Chicago and Wayne State University. Data were presented on 28 patients, each of whom had received at least one infusion of GRN163L at doses ranging from 0.4 - 4.8 mg/kg. A total of 175 doses were administered as of May 12, 2008. Patients had received up to nine prior therapies with more than half receiving four or more.
The plasma half-life was approximately three hours and Cmax appeared to be linear with dose. Dose-limiting toxicity (thrombocytopenia) was observed in one patient at the 3.2 mg/kg dose and in two patients out of 14 at the 4.8 mg/kg dose. No objective responses have been seen at these dose levels.
The maximum tolerated dose of GRN163L has not been established in this heavily pretreated patient population. Dose escalation will continue with evaluation of intermittent dosing schedules to minimize platelet effects. Measurement of hair follicle telomerase activity has been incorporated into the protocol as dose escalation continues in order to define the pharmacokinetic-pharmacodynamic relationship for GRN163L in this patient population.
Gosh, that's not a very Christian attitude... Look at this as a buying opportunity... If and when the political climate changes, and it likely will, the progress at Geron may be quick and substantial, considering all the groundwork being done... I increased my position by a third at $3.85...
Anyone know what happened at 2:22?
What's your logic for shorting QLD instead of buying QID? Or is it all the same, with no advantage or disadvantage either way?
Does that mean you could buy a controlling interest in the company for $2500.01?....BwaaaaHaaHaaHaa........
Unfortuneately, since the markets closed, apparently...
http://business.timesonline.co.uk/tol/business/industry_sectors/banking_and_finance/article3671568.ece
I learned a long time ago that if you want to know if a computer will do something, all you have to do is try it and see. If it allows multiple votes from the same voter, it's a meaningless survey anyway, and there's no harm done. But the fact is that it will not allow you to vote more than once.
OT - A lot of cars get better gas mileage than my Harley Wide Glide
a likely reason for GERN's move...
http://online.wsj.com/article/SB120779366925203837.html?mod=yahoo_hs&ru=yahoo
GERN making higher highs...
iz spelin part of a educayshun
Why do some people have so little difficulty seeing other peoples shortcomings and so much difficulty seeing their own?
Looking at the market action over the next months and years after that was written, I guess we can conclude beyond doubt that that particular theory is so much drivel. The SnP was 103.85 when that article was written. By the end of the year, 4.5 months later, it was at 140.64 - a gain of over 35%. It had doubled within 3.5 years and reached 312.70 by July of 87 - a triple in less than five years. The conditions described in the article sound a lot like today.
Good-bye Zeev...
1B, I'll be glad to get back to you on that, next happy hour...
My Excel spreadsheet tells me that there have been 187 trading days since 1971 when the NASDAQ composite closed at a 52-week low. The average return six months later was 13.8%. A one-year investment returned an average of 25.9%